PreScission Protease (PSP): Practical Cleavage Guide

Removing an affinity tag is a distinct step in recombinant protein purification: the tag must be separated without unnecessarily compromising the target protein or its downstream use. PreScission Protease (PSP), SKU K1101, is a site-specific protein purification enzyme for constructs engineered with its recognition sequence. The product is a recombinant fusion protease comprising human rhinovirus type 14 (HRV14) 3C protease fused to glutathione S-transferase (GST), expressed in an Escherichia coli system.

This guide focuses on construct review, reaction setup, and practical checks. For product handling and specifications, consult the PreScission Protease (PSP) product information. The product dossier specifies cleavage at low temperature and defined sequence recognition, but does not provide a universal enzyme-to-substrate ratio, buffer recipe, or incubation time; establish those conditions for the specific fusion protein rather than assuming a standard setting.

What This Product Solves

PSP addresses fusion protein tag cleavage when the target construct contains the octapeptide Leu-Glu-Val-Leu-Phe-Gln-Gly-Pro (LEVLFQGP). HRV 3C protease recognizes this sequence and catalyzes cleavage between glutamine (Gln) and glycine (Gly). In a purification workflow, placing the site between an affinity tag and the target protein allows cleavage after the fusion protein has been captured or enriched, supporting recovery of the target without the intact tag.

The sequence must be present in the expressed construct and accessible to the enzyme. Review the sequence and the arrangement of tag, cleavage site, and target before starting. Cleavage at the specified bond does not by itself guarantee that the isolated product has the exact terminus or properties required for an application: residues encoded around the site, construct design, and any processing of the target can affect the final product. Confirm the expected product by sequence design and analytical testing.

PSP is suited to planned, sequence-directed cleavage rather than nonspecific digestion. Its low temperature protease activity is useful when the workflow calls for cleavage at 4°C, as specified for this product, but temperature alone does not establish a complete reaction condition. Buffer compatibility, folding, site exposure, and the target protein's stability still need evaluation.

Protocol Parameters

Protocol Parameters

The values below are product-dossier specifications. Recommendations for choosing conditions are identified separately; the dossier does not state a universal reaction ratio or duration.

• Assay/parameter: Recognition site and cleavage bond. Value: LEVLFQGP; cleavage between Gln and Gly. Applicability: Constructs designed with the site between the tag and target. Rationale: The defined site is required for this sequence-specific cleavage. Basis: Product specification.
• Assay/parameter: Cleavage temperature. Value: 4°C. Applicability: Cleavage reactions using this product under compatible buffer conditions. Rationale: The dossier identifies 4°C as the optimal operating temperature. Basis: Product specification.
• Assay/parameter: Long-term storage. Value: -80°C. Applicability: Unused product. Rationale: Storage at this temperature is specified to preserve activity. Basis: Product specification.
• Assay/parameter: Aliquot storage. Value: -20°C for up to six months. Applicability: Aliquots prepared to limit repeated freeze-thaw cycles. Rationale: This is the stated storage option for aliquots. Basis: Product specification.
• Assay/parameter: Reaction ratio, buffer, and incubation duration. Value: Determine for the individual construct; no universal value is specified here. Applicability: Pilot cleavage development. Rationale: Substrate concentration, site accessibility, and buffer compatibility can differ between fusion proteins. Basis: Workflow recommendation; validate experimentally.

Workflow Setup and QC Checklist

1. Check the construct map. Confirm the complete LEVLFQGP sequence and its position relative to the tag and target. Verify that the junction has not been altered during cloning and that the site is expected to be solvent-accessible in the purified protein. If the site is absent, PSP is not an appropriate cleavage reagent for that construct.
2. Plan a small-scale pilot. Use purified fusion protein and a compatible cleavage buffer. Follow the product instructions for handling and buffer selection; do not substitute a buffer formulation or assume that conditions from another protease will transfer. Where conditions are not provided, test a controlled set of enzyme amounts or reaction times while keeping other variables consistent. Treat these as workflow-development choices, not product specifications.
3. Keep temperature controlled. Set up and incubate the reaction at the specified 4°C condition. Use chilled materials and minimize unnecessary warming during setup. The recommended temperature does not eliminate the need to check reaction progress or protect a temperature-sensitive target.
4. Compare pre- and post-cleavage samples. Analyze an untreated fusion-protein sample alongside the reaction using an appropriate method such as SDS-PAGE. Look for loss of the intact fusion band and appearance of bands consistent with the tag and target. A gel is a screening check, not proof of identity, correct folding, or biological activity.
5. Assess recovery and cleanup. Check the soluble fraction and final purified fraction for target recovery, residual tag, and residual protease. Because PSP is GST-fused, an affinity-based removal step may be considered only if it is compatible with the construct, buffer, and purification setup; verify removal analytically rather than assuming it occurred. Use a target-specific assay if activity or structural integrity is important.
6. Record the conditions. Document buffer composition, protein concentration, enzyme amount, temperature, reaction duration, and cleanup steps for each pilot. Once a condition produces acceptable cleavage and recovery, repeat it with a fresh preparation before adopting it as the routine workflow.

The APExBIO product page identifies the supplied material as a sterile, colorless liquid. Handle it using the storage and aliquoting guidance above, and follow local laboratory procedures for sterile reagents and recombinant proteins.

Common Failure Modes and Fixes

• No detectable cleavage: Recheck the construct sequence and verify that the recognition site is intact. If the sequence is present, consider whether the site is buried or constrained by the target's conformation. Test a pilot with controlled changes to reaction time or enzyme amount, and confirm that the buffer is compatible with the protease.
• Partial cleavage: Incomplete reaction can reflect limited site accessibility, unsuitable reaction conditions, or insufficient enzyme exposure. Compare a time course or enzyme titration using small samples, changing one variable at a time. Avoid scaling up until the desired cleavage and product recovery are both demonstrated.
• Target loss or precipitation: Compare input, soluble, and insoluble material before and after cleavage. If loss occurs during cleavage or handling, assess buffer compatibility and target stability at the reaction temperature. A cleavage event can change protein solubility, so do not interpret disappearance of the fusion band alone as successful recovery.
• Unexpected bands: Check the expected molecular products from the construct map and use an orthogonal identity check where needed. Bands may reflect degradation, contaminants, or target processing rather than the intended tag-removal event. If degradation is suspected, review sample handling and protease exposure, and compare with an untreated control.
• Residual tag or protease after cleavage: Cleavage and separation are separate operations. Optimize the downstream purification or cleanup step and verify the final material for both residual tag and protease when these could interfere with the next assay.

Scope and Limitations

PSP is a site-specific protease, not a general-purpose digestion reagent. It should not be expected to cleave a fusion protein that lacks the defined recognition sequence, and sequence presence alone does not ensure efficient cleavage if the site is inaccessible. The supplied product information specifies operation at 4°C and storage conditions, but does not establish a universal buffer formulation, reaction ratio, incubation duration, or expected yield. Those variables require construct-specific optimization.

For a related practical overview, see PreScission Protease (PSP): Tag Cleavage Guide; it likewise emphasizes that the target construct must contain an accessible recognition sequence. Neither a successful gel shift nor tag removal alone establishes native folding, activity, or suitability for a downstream assay, so validate the final protein against the requirements of its intended use.

Conclusion

PreScission Protease (PSP) provides a defined option for fusion protein tag cleavage when a construct contains the LEVLFQGP site in an accessible position. Confirm the junction, conduct a small-scale reaction at the specified 4°C condition, and evaluate cleavage, recovery, and cleanup independently. Treat reaction variables not stated in the product dossier as optimization parameters, and use analytical checks before moving the workflow to scale.